NCT00393913View on ClinicalTrials.gov

Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness

CompletedOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Sleep Apnea, Obstructive
Interventions
DEVICE

Continuous Positive Airway Pressure (CPAP)

Positive airway pressure delivered via a nasal mask titrated to a therapeutic level to eliminate all sleep disordered breathing to be used every night for 4-6 weeks.

Trial Locations (1)

10016

NYU Sleep Disorders Center, New York

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

NYU Langone Health

OTHER

NCT00393913 - Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness | Biotech Hunter | Biotech Hunter